Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Accord Healthcare Announces Acquisition of Essential Pharmaceuticals

By Accord Healthcare | July 27, 2017

Accord Healthcare announced the acquisition of Ewing, NJ-based Essential Pharmaceuticals. Under the terms of the agreement, along with the Essential company, Accord has acquired the rights to sell Custodiol HTK Solution in the United States and Canada. Custodiol HTK Solution is a leading organ preservation solution indicated for perfusion and flushing of donor kidneys, liver, pancreas and heart prior to and after removal from donor.  

“We are thrilled to be expanding on our capabilities of providing life-saving, affordable medicines and therapies to patients and healthcare providers alike. Custodiol HTK is a vital product in the organ donation process and we are excited to include it in our product offering, as well as build upon the research and development programs in place for future organ preservation drug products,” said Gerald Price, president of Accord Healthcare.  

Commenting on the acquisition, Allan Weber, former CEO of Essential said: “As a growth oriented company, we couldn’t have found a better partner than Accord Healthcare. Valued Custodiol HTK customers can expect to see the same familiar faces of our transplant specialists, as well as experience the same outstanding customer service to which they have grown accustomed.”   

Accord Healthcare is the 12th largest generic pharmaceutical firm in the United States, per IMS Health.  The company’s U.S. headquarters is in Durham, NC. It is a part of the Intas Group, headquartered in Ahmedabad, India.

(Source: PR Newswire)

Related Articles Read More >

Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE